USP and SAHPRA: A Partnership for Health Regulatory Excellence
By Danélia Botes
September 14, 2023
The United States Pharmacopeia (USP) recently welcomed an executive delegation from the South African Health Products Regulatory Authority (SAHPRA) to its Rockville headquarters. This visit marked the culmination of a two-part series, during which both organisations exchanged ideas and explored areas of expanded technical collaboration. Strengthening the Bond In 2022, USP and SAHPRA signed a Memorandum of Understanding (MOU) aiming to expand the availability of health products that are safe, effective, and of assured quality. The partnership also seeks to support SAHPRA in achieving the World Health Organization Maturity Level 4, a status that distinguishes regulatory systems operating at the most advanced levels of performance. The Road Ahead SAHPRA CEO Dr. Boitumelo Semete-Makokotlela expressed optimism about the partnership. She stated that the collaboration with USP would bolster their ability to respond to today’s regulatory challenges using state-of-the-art science in quality assurance and regulatory practice. A Commitment to Global Health In December 2022, the Promoting the Quality of Medicines Plus (PQM+) program, funded by the U.S. Agency for International Development and implemented by USP, organized a joint workshop with SAHPRA. The workshop aimed to strengthen regulatory oversight of vaccines in the region as part of the U.S. Government’s Global VAX initiative. About the Organizations SAHPRA’s mandate includes regulating all health products, overseeing radiation control, and ensuring the safety, efficacy, and quality of medicines, medical devices, and in-vitro diagnostics (IVDs). Similarly, the USP is an independent, scientific nonprofit organisation working to strengthen the global supply chain for safe, quality medicines. The PQM+ Program is a cooperative agreement between USAID and USP to sustainably strengthen medical product quality assurance systems in low- and middle-income countries.
📢Latest update on the NHI! 📢 Dive into our latest piece on the judicial review of the South African National Health Insurance Bill. Learn about the intriguing case and its implications on the healthcare industry. 🏛️💼💡 #HealthcarePolicy #LegalReview #NationalHealthInsuranceBill
Discover the global perspective on orphan medicines and their role in treating rare diseases. Learn about the unique challenges and incentives in their development. 🌍💊 #OrphanMedicines #RareDiseases #HealthcareInnovation #RareDiseaseDay. Read more here
📚 New research findings alert! 🚨 A recent study shows that increasing coverage of maternal, child and inpatient services is associated with reduced poverty in low and middle-income countries. 💡 This supports pro-poor approaches towards Universal Health Coverage. 🌍 Let’s work together to ensure #HealthForAll and #EndPoverty. Read more here 📖 #UHC #GlobalHealth #HealthEquity
When you partner with Syenza, it’s like a Nuclear Fusion.
Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in
health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.